Hepatitis B Infection Prevalence, Genotype Distribution, and Knowledge of Mother- To-Child Transmission Among Antenatal Care Attendees in Yako, Rural Burkina Faso - Serge Ouoba

Conference on Liver Disease in Africa (COLDA) 2022

Hepatitis B Birth Dose Coverage Remains Dramatically Low in the Gambia and Has Been Disrupted by the COVID-19 Pandemic - Gibril Ndow

Conference on Liver Disease in Africa (COLDA) 2022

Can Integration Reduce Stigma? / Lessons Learned from HIV - Danjuma Adda, MPH, FIMS, Dip-IMS

Conference on Liver Disease in Africa (COLDA) 2022

Integrated Decentralized Guidelines for Care – WHO Guidelines - Philippa Easterbrook, MD, FRCP, MPH, DTM&H

Conference on Liver Disease in Africa (COLDA) 2022

Vertical Transmission, Maternal Care, and Family Care - Manal El-Sayed, MD, PhD

Conference on Liver Disease in Africa (COLDA) 2022

Blood Safety & Surveillance - Yuyun S. Maryuningsih, MD, PhD

Conference on Liver Disease in Africa (COLDA) 2022

From Pandemic Response to Pandemic Recovery - Opportunities for Viral Hepatitis Elimination - John Ward, MD

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “Call for Action - “We Need Testing and Treatment - NOW” - Bisi Bright, B.Pharm(Hons), MPH, FPCPharm, FPSN, C.Psych

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “We Need Solutions” - Agnes Binagwaho, MD, M(Ped), PhD

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “We Need (HQ) Data - To Plan Services” - Olufunmilayo Lesi, MD, MBA, FMCP

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “We Need to Address the Challenges - Now” - The South African Experience - Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD

Conference on Liver Disease in Africa (COLDA) 2022

Roundtable Discussion: Industry Developments Advancing Comprehensive Care Models for NAFLD

Innovations in NAFLD Care Workshop 2022

Roundtable Discussion: the NAFLD Continuum of Care - Patient Organization Session

Innovations in NAFLD Care Workshop 2022

Exchanging and Sharing Ideas on the NAFLD/NASH Roadmap Including Social Media and Digital Transformation of Health Care - Roundtable discussion Session 6

Innovations in NAFLD Care Workshop 2022

The Liver-Heart Axis – Does NASH Drive Cardiovascular Disease? - Sven Francque, MD, PhD video

Innovations in NAFLD Care Workshop 2022

Is NAFLD/NASH a Public Health Challenge in 2022? - Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF, FAASLD video

Innovations in NAFLD Care Workshop 2022

Fatal Triple – Linking Obesity, Type-2 Diabetes, and NASH - Cyrielle Caussy, MD, PhD video

Innovations in NAFLD Care Workshop 2022

Liver-Directed Drugs in the Pipeline for Fibrotic NASH - Stephen Harrison, M.D, FACP, FAASLD Col (ret.) video

Innovations in NAFLD Care Workshop 2022

Pharmacotherapy for Obesity - Improving Body Weight and NAFLD - Naim Alkhouri, MD video

Innovations in NAFLD Care Workshop 2022

Why and How to Identify NAFLD in Primary Care? - Jean Muris, MD PhD video

Innovations in NAFLD Care Workshop 2022

The Central Role of Primary Care in the NASH Epidemic: Opportunities and Challenges - Helen Jarvis, MD Video

Innovations in NAFLD Care Workshop 2022

Using the Power of Digital Innovation - Apps Transforming Weight Management - Marcus Ranney, MD VIDEO

Innovations in NAFLD Care Workshop 2022

The Road to Comprehensive Models of Care for NAFLD - What Are the Endpoints? - Jeffrey Lazarus, PhD, MIH, MA video

Innovations in NAFLD Care Workshop 2022

Integrating Non-Invasive Tests for NAFLD in Clinical Practice Outside the Liver Space - Which Test and at What Level? - Alina Allen, MD video

Innovations in NAFLD Care Workshop 2022